| 產品名稱 |
Streptomyces lasaliensis |
| 商品貨號 |
B192961 |
| Strain Designations |
X-537, subculture 536-3-35 [NRRL 3382] |
| Application |
Produces lasalocid X-537A, lasalocid A |
| Isolation |
Soil, Hyde Park, MA |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Preceptrol® |
no |
| Type Strain |
no |
| Medium |
ATCC® Medium 1877: ISP Medium 1
ATCC® Medium 196: Yeast malt extract agar
|
| Growth Conditions |
Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor |
Hoffmann-La Roche Ltd. |
| U.S. Patent Number |
|
| Chain of Custody |
ATCC <-- Hoffmann-La Roche Ltd. <-- J. Berger |
| References |
Westley J. Homologs of lasalocid A. US Patent 4,168,272 dated Sep 18 1979
Westley J. Resolution of certain asymmetric primary amines using lasalocid. US Patent 4,129,580 dated Dec 12 1978
|
